Pharma Mar Balance Sheet Health
Financial Health criteria checks 6/6
Pharma Mar has a total shareholder equity of €216.9M and total debt of €39.8M, which brings its debt-to-equity ratio to 18.3%. Its total assets and total liabilities are €373.7M and €156.8M respectively. Pharma Mar's EBIT is €20.5M making its interest coverage ratio 9.5. It has cash and short-term investments of €183.1M.
Key information
18.3%
Debt to equity ratio
€39.78m
Debt
Interest coverage ratio | 9.5x |
Cash | €183.13m |
Equity | €216.93m |
Total liabilities | €156.79m |
Total assets | €373.72m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHM1 N's short term assets (€257.5M) exceed its short term liabilities (€89.0M).
Long Term Liabilities: PHM1 N's short term assets (€257.5M) exceed its long term liabilities (€67.8M).
Debt to Equity History and Analysis
Debt Level: PHM1 N has more cash than its total debt.
Reducing Debt: PHM1 N's debt to equity ratio has reduced from 468.1% to 18.3% over the past 5 years.
Debt Coverage: PHM1 N's debt is well covered by operating cash flow (96.3%).
Interest Coverage: PHM1 N's interest payments on its debt are well covered by EBIT (9.5x coverage).